$942 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 168 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRTX | New | VERTEX PHARMACEUTICALS | $14,811,000 | – | 76,846 | +100.0% | 1.57% | – |
| ATRC | New | ATRICURE INC | $8,786,000 | – | 250,824 | +100.0% | 0.93% | – |
| RCM | New | R1 RCM INC | $7,475,000 | – | 735,723 | +100.0% | 0.79% | – |
| RARX | New | RA PHARMACEUTICALS | $6,308,000 | – | 348,712 | +100.0% | 0.67% | – |
| NITE | New | NIGHTSTAR THERAPEUTICSadr | $4,868,000 | – | 238,256 | +100.0% | 0.52% | – |
| AGIO | New | AGIOS PHARMACEUTICS | $4,335,000 | – | 56,207 | +100.0% | 0.46% | – |
| MTEM | New | MOLECULAR TEMPLATES | $1,887,000 | – | 350,000 | +100.0% | 0.20% | – |
| TNDM | New | TANDEM DIABETES CARE | $1,841,000 | – | 42,967 | +100.0% | 0.20% | – |
| BGNE | New | BEIGENE LIMITEDsp adr | $1,710,000 | – | 9,927 | +100.0% | 0.18% | – |
| AGN | New | ALLERGAN PLC | $1,480,000 | – | 7,771 | +100.0% | 0.16% | – |
| TMO | New | THERMO FISHER SCIENTIFIC | $1,110,000 | – | 4,549 | +100.0% | 0.12% | – |
| SGEN | New | SEATTLE GENETICS INC | $1,013,000 | – | 13,130 | +100.0% | 0.11% | – |
| HCM | New | HUTCHISON CHINA MEDITECHsp adr | $1,018,000 | – | 31,628 | +100.0% | 0.11% | – |
| NVTA | New | INVITAE CORP | $956,000 | – | 57,144 | +100.0% | 0.10% | – |
| ANTM | New | ANTHEM INC | $929,000 | – | 3,391 | +100.0% | 0.10% | – |
| ALKS | New | ALKERMES PLC | $874,000 | – | 20,585 | +100.0% | 0.09% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES | $836,000 | – | 6,803 | +100.0% | 0.09% | – |
| BDX | New | BECTON DICKINSON | $787,000 | – | 3,015 | +100.0% | 0.08% | – |
| HCA | New | HCA HEALTHCARE | $735,000 | – | 5,286 | +100.0% | 0.08% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL | $691,000 | – | 9,047 | +100.0% | 0.07% | – |
| New | EDWARDS LIFESCIENCES | $645,000 | – | 3,705 | +100.0% | 0.07% | – | |
| WCG | New | WELLCARE HEALTH PLAN | $603,000 | – | 1,881 | +100.0% | 0.06% | – |
| BIIB | New | BIOGEN INC | $587,000 | – | 1,662 | +100.0% | 0.06% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $554,000 | – | 1,370 | +100.0% | 0.06% | – |
| LOXO | New | LOXO ONCOLOGY INC | $546,000 | – | 3,195 | +100.0% | 0.06% | – |
| MYL | New | MYLAN N V | $524,000 | – | 14,329 | +100.0% | 0.06% | – |
| MCK | New | MCKESSON CORP | $510,000 | – | 3,842 | +100.0% | 0.05% | – |
| ATHN | New | ATHENAHEALTH INC | $498,000 | – | 3,724 | +100.0% | 0.05% | – |
| HRTX | New | HERON THERAPEUTICS | $482,000 | – | 15,243 | +100.0% | 0.05% | – |
| CHRS | New | COHERUS BIOSCIENCES | $462,000 | – | 27,987 | +100.0% | 0.05% | – |
| DERM | New | DERMIRA INC | $457,000 | – | 41,902 | +100.0% | 0.05% | – |
| BLUE | New | BLUEBIRD BIO INC | $432,000 | – | 2,957 | +100.0% | 0.05% | – |
| CERS | New | CERUS CORP | $437,000 | – | 60,576 | +100.0% | 0.05% | – |
| HMSY | New | HMS HOLDINGS CORP | $404,000 | – | 12,307 | +100.0% | 0.04% | – |
| DHR | New | DANAHER CORP | $386,000 | – | 3,556 | +100.0% | 0.04% | – |
| KALV | New | KALVISTA PHARMACEUTICALS | $388,000 | – | 17,551 | +100.0% | 0.04% | – |
| AKCA | New | AKCEA THERAPEUTICS | $363,000 | – | 10,356 | +100.0% | 0.04% | – |
| SYK | New | STRYKER CORP | $367,000 | – | 2,066 | +100.0% | 0.04% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $359,000 | – | 626 | +100.0% | 0.04% | – |
| MNTA | New | MOMENTA PHARMACEUTICAKS | $354,000 | – | 13,458 | +100.0% | 0.04% | – |
| UHS | New | UNIVERSAL HEALTH SVCcl b | $359,000 | – | 2,811 | +100.0% | 0.04% | – |
| ARNA | New | ARENA PHARMACEUTICALS | $332,000 | – | 7,208 | +100.0% | 0.04% | – |
| CAH | New | CARDINAL HEALTH INC | $333,000 | – | 6,171 | +100.0% | 0.04% | – |
| BPMC | New | BLUEPRINT MEDICINES | $327,000 | – | 4,184 | +100.0% | 0.04% | – |
| RIGL | New | RIGEL PHARMACEUTICALS | $317,000 | – | 98,609 | +100.0% | 0.03% | – |
| HUM | New | HUMANA INC | $321,000 | – | 949 | +100.0% | 0.03% | – |
| STML | New | STEMLINE THERAPEUTICS | $308,000 | – | 18,538 | +100.0% | 0.03% | – |
| CNC | New | CENTENE CORP DEL | $303,000 | – | 2,090 | +100.0% | 0.03% | – |
| XENT | New | INTERSECT ENT INC | $294,000 | – | 10,226 | +100.0% | 0.03% | – |
| GSK | New | GLAXOSMITHKLINE PLCsp adr | $293,000 | – | 7,300 | +100.0% | 0.03% | – |
| MDCO | New | MEDICINES CO | $288,000 | – | 9,614 | +100.0% | 0.03% | – |
| RTRX | New | RETROPHIN INC | $288,000 | – | 10,036 | +100.0% | 0.03% | – |
| RVNC | New | REVANCE THERAPEUTICS | $279,000 | – | 11,234 | +100.0% | 0.03% | – |
| AZN | New | ASTRAZENECAsp adr | $281,000 | – | 7,100 | +100.0% | 0.03% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS | $284,000 | – | 15,400 | +100.0% | 0.03% | – |
| ACRX | New | ACELRX PHARMACEUTICALS | $284,000 | – | 73,778 | +100.0% | 0.03% | – |
| ICLR | New | ICON PLC | $274,000 | – | 1,780 | +100.0% | 0.03% | – |
| ZBH | New | ZIMMER BIOMET HLDGS | $276,000 | – | 2,099 | +100.0% | 0.03% | – |
| STE | New | STERIS PLC | $275,000 | – | 2,406 | +100.0% | 0.03% | – |
| RGNX | New | REGENXBIO INC | $267,000 | – | 3,533 | +100.0% | 0.03% | – |
| TBPH | New | THERAVANCE BIOPHARMA | $260,000 | – | 7,945 | +100.0% | 0.03% | – |
| MYOK | New | MYOKARDIA INC | $264,000 | – | 4,051 | +100.0% | 0.03% | – |
| BAX | New | BAXTER INTL INC | $254,000 | – | 3,298 | +100.0% | 0.03% | – |
| SYNH | New | SYNEOS HEALTH INCcl a | $250,000 | – | 4,841 | +100.0% | 0.03% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE | $249,000 | – | 3,418 | +100.0% | 0.03% | – |
| AET | New | AETNA INC | $232,000 | – | 1,143 | +100.0% | 0.02% | – |
| ECYT | New | ENDOCYTE INC | $233,000 | – | 13,141 | +100.0% | 0.02% | – |
| CCXI | New | CHEMOCENTRYX INC | $225,000 | – | 17,811 | +100.0% | 0.02% | – |
| BLRX | New | BIOLINERX LTDsp adr | $212,000 | – | 198,297 | +100.0% | 0.02% | – |
| TEVA | New | TEVA PHARMACEUTICALsp adr | $218,000 | – | 10,120 | +100.0% | 0.02% | – |
| NUVA | New | NUVASIVE INC | $211,000 | – | 2,975 | +100.0% | 0.02% | – |
| KANG | New | IKANG HEALTHCARE GROUPsp adr | $208,000 | – | 11,513 | +100.0% | 0.02% | – |
| KURA | New | KURA ONCOLOGY INC | $207,000 | – | 11,800 | +100.0% | 0.02% | – |
| AMRX | New | AMNEAL PHARMACEUTICALS | $201,000 | – | 9,040 | +100.0% | 0.02% | – |
| GTHX | New | G1 THERAPEUTICS | $202,000 | – | 3,857 | +100.0% | 0.02% | – |
| IMGN | New | IMMUNOGEN INC | $199,000 | – | 21,013 | +100.0% | 0.02% | – |
| OSUR | New | ORASURE TECHNOLOGIES | $195,000 | – | 12,609 | +100.0% | 0.02% | – |
| FPRX | New | FIVE PRIME THERAPEUTICS | $194,000 | – | 13,920 | +100.0% | 0.02% | – |
| CTMX | New | CYTOMX THERAPEUTICS | $186,000 | – | 10,058 | +100.0% | 0.02% | – |
| MEIP | New | MEI PHARMA INC | $192,000 | – | 44,539 | +100.0% | 0.02% | – |
| MRNS | New | MARINUS PHARMACEUTICALS | $168,000 | – | 16,800 | +100.0% | 0.02% | – |
| CBAY | New | CYMABAY THERAPEUTICS | $170,000 | – | 15,367 | +100.0% | 0.02% | – |
| ABEO | New | ABEONA THERAPEUTICS | $162,000 | – | 12,681 | +100.0% | 0.02% | – |
| ATRS | New | ANTARES PHARMA INC | $159,000 | – | 47,280 | +100.0% | 0.02% | – |
| CLSD | New | CLEARSIDE BIOMEDICAL | $160,000 | – | 25,959 | +100.0% | 0.02% | – |
| CYTK | New | CYTOKINETICS INC | $153,000 | – | 15,582 | +100.0% | 0.02% | – |
| BDSI | New | BIODELIVERY SCIENCES | $152,000 | – | 54,434 | +100.0% | 0.02% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS | $146,000 | – | 12,957 | +100.0% | 0.02% | – |
| ADRO | New | ADURO BIOTECH INC | $139,000 | – | 18,921 | +100.0% | 0.02% | – |
| QTNT | New | QUOTIENT LTD | $133,000 | – | 17,649 | +100.0% | 0.01% | – |
| AGLE | New | AEGLEA BIOTHERAPEUTICS | $124,000 | – | 12,954 | +100.0% | 0.01% | – |
| PRTK | New | PARATEK PHARMACEUTICALS | $124,000 | – | 12,739 | +100.0% | 0.01% | – |
| AVEO | New | AVEO PHARMACUTICALS | $119,000 | – | 36,000 | +100.0% | 0.01% | – |
| CDTX | New | CIDARA THERAPEUTICS | $112,000 | – | 25,447 | +100.0% | 0.01% | – |
| TTPH | New | TETRAPHASE PHARMACEUTICALS | $110,000 | – | 39,821 | +100.0% | 0.01% | – |
| New | PROTAGONIST THERAPEUTICS | $117,000 | – | 11,400 | +100.0% | 0.01% | – | |
| PGNX | New | PROGENICS PHARMACEUTICALS | $113,000 | – | 18,002 | +100.0% | 0.01% | – |
| CRVS | New | CORVUS PHARMACEUTICALS | $108,000 | – | 12,594 | +100.0% | 0.01% | – |
| New | NABRIVA THERAPEUTICS | $103,000 | – | 38,255 | +100.0% | 0.01% | – | |
| PLX | New | PROTALIX BIOTHERAPEUTICS | $72,000 | – | 99,667 | +100.0% | 0.01% | – |
| AVDL | New | AVADEL PHARMACEUTICALSsp adr | $67,000 | – | 15,218 | +100.0% | 0.01% | – |
| CTIC | New | CTI BIOPHARMA CORP | $70,000 | – | 32,241 | +100.0% | 0.01% | – |
| CNAT | New | CONATUS PHARMACEUTICALS | $60,000 | – | 10,364 | +100.0% | 0.01% | – |
| SLNO | New | SOLENO THERAPEUTICS | $47,000 | – | 21,587 | +100.0% | 0.01% | – |
| SNSS | New | SUNESIS PHARMACEUTICALS | $24,000 | – | 12,000 | +100.0% | 0.00% | – |
| GNCA | New | GENOCEA BIOSCIENCES | $26,000 | – | 32,936 | +100.0% | 0.00% | – |
| AGRX | New | AGILE THERAPEUTICS | $16,000 | – | 45,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.